SEQUENT SCIENTIFIC
Quarterly Results Analysis [Dec2023]
SEQUENT SCIENTIFIC Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 Audited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹329 Cr | ₹346 Cr | ₹333 Cr | ₹367 Cr | ₹375 Cr | ₹338 Cr | ₹341 Cr | ₹384 Cr |
Expenses | ₹307 Cr | ₹331 Cr | ₹341 Cr | ₹370 Cr | ₹365 Cr | ₹335 Cr | ₹339 Cr | ₹350 Cr |
Operating Income | ₹22 Cr | ₹15 Cr | ₹-8 Cr | ₹-3 Cr | ₹10 Cr | ₹3 Cr | ₹2 Cr | ₹33 Cr |
Other Income | ₹5 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr | ₹4 Cr |
Interest | ₹13 Cr | ₹13 Cr | ₹10 Cr | ₹11 Cr | ₹10 Cr | ₹8 Cr | ₹7 Cr | ₹6 Cr |
Depreciation | ₹15 Cr | ₹15 Cr | ₹14 Cr | ₹15 Cr | ₹14 Cr | ₹13 Cr | ₹14 Cr | ₹13 Cr |
Profit Before Tax | ₹1 Cr | ₹-3 Cr | ₹-56 Cr | ₹-89 Cr | ₹-10 Cr | ₹-18 Cr | ₹-21 Cr | ₹18 Cr |
Profit After Tax | ₹11 Cr | ₹-7 Cr | ₹-35 Cr | ₹-92 Cr | ₹-10 Cr | ₹-4 Cr | ₹-15 Cr | ₹10 Cr |
EPS | ₹0.33 | ₹-0.34 | ₹-1.40 | ₹-3.75 | ₹-0.36 | ₹-0.15 | ₹-0.60 | ₹0.36 |
Industry Peers & Returns | 1W | 1M | 1Y |
SEQUENT SCIENTIFIC | 4.7% | 8.3% | 67.4% |
SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -2.8% | 50.3% |
CIPLA | 4.5% | -3.1% | 52.8% |
DR REDDYS LABORATORIES | 4.6% | 1.4% | 22.2% |
ZYDUS LIFESCIENCES | 3.1% | -4.1% | 80.4% |
DIVIS LABORATORIES | 4.7% | 10.8% | 18.1% |
MANKIND PHARMA | 2.7% | 12.4% | NA |
TORRENT PHARMACEUTICALS | 6.1% | 5.3% | 66.2% |
LUPIN | 3.1% | -1.1% | 127.4% |
SEQUENT SCIENTIFIC Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -4.80 % |
Y-o-Y | -12.24 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹329 Cr | -4.80 | |
Sep2023 | ₹346 Cr | 3.83 | |
Jun2023 | ₹333 Cr | -9.13 | |
Mar2023 | ₹367 Cr | -2.30 | |
Dec2022 | ₹375 Cr | 11.17 | |
Sep2022 | ₹338 Cr | -1.09 | |
Jun2022 | ₹341 Cr | -11.05 | |
Mar2022 | ₹384 Cr | - |
SEQUENT SCIENTIFIC Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 47.04 % |
Y-o-Y | 115.24 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹22 Cr | 47.04 | |
Sep2023 | ₹15 Cr | Positive | |
Jun2023 | ₹-8 Cr | Negative | |
Mar2023 | ₹-3 Cr | Negative | |
Dec2022 | ₹10 Cr | 260.17 | |
Sep2022 | ₹3 Cr | 35.63 | |
Jun2022 | ₹2 Cr | -93.65 | |
Mar2022 | ₹33 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 54.69 % |
Y-o-Y | 145.82 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 6.76% | 54.69 | |
Sep2023 | 4.37% | Positive | |
Jun2023 | -2.47% | Negative | |
Mar2023 | -0.92% | Negative | |
Dec2022 | 2.75% | 223.53 | |
Sep2022 | 0.85% | 37.10 | |
Jun2022 | 0.62% | -92.87 | |
Mar2022 | 8.69% | - |
SEQUENT SCIENTIFIC Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Positive |
Y-o-Y | Positive |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹11 Cr | Positive | |
Sep2023 | ₹-7 Cr | Negative | |
Jun2023 | ₹-35 Cr | Negative | |
Mar2023 | ₹-92 Cr | Negative | |
Dec2022 | ₹-10 Cr | Negative | |
Sep2022 | ₹-4 Cr | Negative | |
Jun2022 | ₹-15 Cr | Negative | |
Mar2022 | ₹10 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Positive |
Y-o-Y | Positive |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 3.24 % | Positive | |
Sep2023 | -1.99 % | Negative | |
Jun2023 | -10.41 % | Negative | |
Mar2023 | -25.21 % | Negative | |
Dec2022 | -2.61 % | Negative | |
Sep2022 | -1.32 % | Negative | |
Jun2022 | -4.49 % | Negative | |
Mar2022 | 2.58 % | - |
SEQUENT SCIENTIFIC Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Positive |
Y-o-Y | Positive |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹0.33 | Positive | |
Sep2023 | ₹-0.34 | Negative | |
Jun2023 | ₹-1.4 | Negative | |
Mar2023 | ₹-3.75 | Negative | |
Dec2022 | ₹-0.36 | Negative | |
Sep2022 | ₹-0.15 | Negative | |
Jun2022 | ₹-0.6 | Negative | |
Mar2022 | ₹0.36 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD